Literature DB >> 21813599

Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.

Yoshiaki Nishimura1, Masashi Shingai, Wendy R Lee, Reza Sadjadpour, Olivia K Donau, Ronald Willey, Jason M Brenchley, Ranjini Iyengar, Alicia Buckler-White, Tatsuhiko Igarashi, Malcolm A Martin.   

Abstract

Evolution of the env gene in transmitted R5-tropic human immunodeficiency virus type 1 (HIV-1) strains is the most widely accepted mechanism driving coreceptor switching. In some infected individuals, however, a shift in coreceptor utilization can occur as a result of the reemergence of a cotransmitted, but rapidly controlled, X4 virus. The latter possibility was studied by dually infecting rhesus macaques with X4 and R5 chimeric simian simian/human immunodeficiency viruses (SHIVs) and monitoring the replication status of each virus using specific primer pairs. In one of the infected monkeys, both SHIVs were potently suppressed by week 12 postinoculation, but a burst of viremia at week 51 was accompanied by an unrelenting loss of total CD4+ T cells and the development of clinical disease. PCR analyses of plasma viral RNA indicated an env gene segment containing the V3 region from the inoculated X4 SHIV had been transferred into the genetic background of the input R5 SHIV by intergenomic recombination, creating an X4 virus with novel replicative, serological, and pathogenic properties. These results indicate that the effects of retrovirus recombination in vivo can be functionally profound and may even occur when one of the recombination participants is undetectable in the circulation as cell-free virus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813599      PMCID: PMC3187496          DOI: 10.1128/JVI.05010-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.

Authors:  G Pollakis; S Kang; A Kliphuis; M I Chalaby; J Goudsmit; W A Paxton
Journal:  J Biol Chem       Date:  2001-01-16       Impact factor: 5.157

2.  Identification and comparison of eleven rhesus macaque chemokine receptors.

Authors:  B J Margulies; D A Hauer; J E Clements
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-01       Impact factor: 2.205

3.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Development and homeostasis of T cell memory in rhesus macaque.

Authors:  Christine J Pitcher; Shoko I Hagen; Joshua M Walker; Richard Lum; Bridget L Mitchell; Vernon C Maino; Michael K Axthelm; Louis J Picker
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.

Authors:  T Igarashi; Y Endo; G Englund; R Sadjadpour; T Matano; C Buckler; A Buckler-White; R Plishka; T Theodore; R Shibata; M Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.

Authors:  Yoshiaki Nishimura; Masashi Shingai; Ronald Willey; Reza Sadjadpour; Wendy R Lee; Charles R Brown; Jason M Brenchley; Alicia Buckler-White; Rahel Petros; Michael Eckhaus; Victoria Hoffman; Tatsuhiko Igarashi; Malcolm A Martin
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

7.  Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

Authors:  W Resch; N Hoffman; R Swanstrom
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

8.  Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.

Authors:  Y Zhang; B Lou; R B Lal; A Gettie; P A Marx; J P Moore
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.

Authors:  Y Endo; T Igarashi; Y Nishimura; C Buckler; A Buckler-White; R Plishka; D S Dimitrov; M A Martin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate.

Authors:  M W Cho; M K Lee; C H Chen; T Matthews; M A Martin
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

View more
  7 in total

1.  Suboptimal provirus expression explains apparent nonrandom cell coinfection with HIV-1.

Authors:  Christelle Brégnard; Gregory Pacini; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

2.  Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.

Authors:  Rajeev Gautam; Yoshiaki Nishimura; Wendy R Lee; Olivia Donau; Alicia Buckler-White; Masashi Shingai; Reza Sadjadpour; Stephen D Schmidt; Celia C LaBranche; Brandon F Keele; David Montefiori; John R Mascola; Malcolm A Martin
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Identifying recombination hot spots in the HIV-1 genome.

Authors:  Redmond P Smyth; Timothy E Schlub; Andrew J Grimm; Caryll Waugh; Paula Ellenberg; Abha Chopra; Simon Mallal; Deborah Cromer; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

4.  An infectious molecular clone in early infection with HIV-1 subtype CRF01_AE strains: construction and biological properties.

Authors:  Hong-Wei Wang; Bin Zhu; Li-Juan Hou; Guang-Jian Lu; Lu-Yang Jiao; Bao-Sheng Shen
Journal:  Mol Biol Rep       Date:  2014-11-06       Impact factor: 2.316

5.  Patterns of genomic site inheritance in HIV-1M inter-subtype recombinants delineate the most likely genomic sites of subtype-specific adaptation.

Authors:  Marcel Tongo; Tulio de Oliveira; Darren P Martin
Journal:  Virus Evol       Date:  2018-06-11

6.  Modular nature of simian foamy virus genomes and their evolutionary history.

Authors:  Pakorn Aiewsakun; Léa Richard; Antoine Gessain; Augustin Mouinga-Ondémé; Philippe Vicente Afonso; Aris Katzourakis
Journal:  Virus Evol       Date:  2019-10-16

7.  Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.

Authors:  Hongshuo Song; Elena E Giorgi; Vitaly V Ganusov; Fangping Cai; Gayathri Athreya; Hyejin Yoon; Oana Carja; Bhavna Hora; Peter Hraber; Ethan Romero-Severson; Chunlai Jiang; Xiaojun Li; Shuyi Wang; Hui Li; Jesus F Salazar-Gonzalez; Maria G Salazar; Nilu Goonetilleke; Brandon F Keele; David C Montefiori; Myron S Cohen; George M Shaw; Beatrice H Hahn; Andrew J McMichael; Barton F Haynes; Bette Korber; Tanmoy Bhattacharya; Feng Gao
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.